Among the different FFARs that have been identified, there is particular interest in the physiological roles of FFAR2/GPR43 and its potential use as a novel therapeutic target in health disorders, such as obesity and insulin resistance (Tiwari, 2010; Hudson et al., 2012). The gene discussed is FFAR2; the disease is obesity due to melanocortin 4 receptor deficiency.